Skip to main content

Table 2 Table shows daemographic data, SVR (in months) and ADRs according to overall enrolled population, genotype (Gt) and disease stage (chirrosis and chronic hepatitis C F3 stage according to metavir)

From: Safety of new DAAs for chronic HCV infection in a real life experience: role of a surveillance network based on clinician and hospital pharmacist

  CHIRROSIS CHC TOT
ADRs 20/51 15/27 35/78
Sex M 44 – F 22 M 14 – F 4 M 58 - F 26
Age <65: 10 <65: 17 <65: 27
>65:41 >65:11 >65:51
Genotype in overall population
 Gt 1 38 20 58
 Gt 2 9 5 14
 Gt 3 4 2 6
SVR in over all population
 SVR 3 mts 44/51 25/27 69/78
 SVR 6 mts 44/51 24/27 68/78
 RELAPSE 6/51 4/27 10/78